Phathom Pharmaceuticals, Inc. — Director's Dealing 2024

Jun 1, 2024

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Phathom Pharmaceuticals, Inc. (PHAT)
CIK: 0001783183
Period of Report: 2024-05-31

Reporting Person: Henderson Molly (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2024-05-31	Common Stoock	A	7500	—	Acquired	102763	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	1911.27	Indirect

Footnotes

F1: Represents restricted stock units ("RSUs") granted on May 31, 2024. One third (1/3) of the total number of RSUs granted vest on each of the first three anniversaries of December 18, 2023, the vesting commencement date, subject to the Reporting Person's continued service on the applicable vesting date. Each RSU represents a contingent right to receive one share of common stock of the Issuer.